首页 > 最新文献

Journal of cancer & allied specialties最新文献

英文 中文
Recent Changes to the Editorial Policies. 编辑策略的最新更改。
Pub Date : 2020-01-06 eCollection Date: 2020-01-01 DOI: 10.37029/jcas.v6i1.325
Khawaja Shehryar Nasir
An overview of the recent editorial and structural changes that have taken place in the Journal of Cancer & Allied Specialties.
{"title":"Recent Changes to the Editorial Policies.","authors":"Khawaja Shehryar Nasir","doi":"10.37029/jcas.v6i1.325","DOIUrl":"10.37029/jcas.v6i1.325","url":null,"abstract":"An overview of the recent editorial and structural changes that have taken place in the Journal of Cancer & Allied Specialties.","PeriodicalId":73631,"journal":{"name":"Journal of cancer & allied specialties","volume":"6 1","pages":"e325"},"PeriodicalIF":0.0,"publicationDate":"2020-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8e/4b/JCAS-6-325.PMC10166304.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9481400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tele-Oral Oncology: Reinvigorating Telemedicine in Oral Cancer Care. 口腔远程肿瘤:在口腔癌症护理中振兴远程医疗。
Pub Date : 2020-01-06 eCollection Date: 2020-01-01 DOI: 10.37029/jcas.v6i1.335
Zaid H Khoury, Ahmed S Sultan

Introduction: In recent years, we have witnessed significant growth in the employment of technological advancements in health-care practices. These advancements have increased the practicality and utility of telemedicine applications. The aim of this focused review is to provide in-depth insights into the current state of telemedicine in oral oncology.

Observations: Tele-oral oncology (TOO) is a rapidly emerging field and has provided new opportunities to transform oral cancer care into the 22nd century. This review will explore topics related to TOO as they pertain to consultation, oral cancer management in underserved areas, patient education and e-learning applications.

Conclusion and relevance: The utilisation of TOO is hindered by many challenges and this review addresses the potential limitations that prevent the integration of TOO in routine oral cancer care. A working model that circumvents the potential shortcomings of TOO is also proposed.

引言:近年来,我们见证了医疗保健实践中技术进步的就业大幅增长。这些进步提高了远程医疗应用的实用性和实用性。这篇重点综述的目的是深入了解口腔肿瘤学远程医疗的现状。观察结果:远处肿瘤(TOO)是一个快速发展的领域,为将癌症口腔护理转变到22世纪提供了新的机会。这篇综述将探讨与TOO相关的主题,因为它们涉及咨询、服务不足地区的口腔癌症管理、患者教育和电子学习应用。结论和相关性:TOO的使用受到许多挑战的阻碍,本综述解决了阻碍TOO在常规口腔癌症护理中整合的潜在限制。还提出了一种规避TOO潜在缺点的工作模型。
{"title":"Tele-Oral Oncology: Reinvigorating Telemedicine in Oral Cancer Care.","authors":"Zaid H Khoury,&nbsp;Ahmed S Sultan","doi":"10.37029/jcas.v6i1.335","DOIUrl":"10.37029/jcas.v6i1.335","url":null,"abstract":"<p><strong>Introduction: </strong>In recent years, we have witnessed significant growth in the employment of technological advancements in health-care practices. These advancements have increased the practicality and utility of telemedicine applications. The aim of this focused review is to provide in-depth insights into the current state of telemedicine in oral oncology.</p><p><strong>Observations: </strong>Tele-oral oncology (TOO) is a rapidly emerging field and has provided new opportunities to transform oral cancer care into the 22nd century. This review will explore topics related to TOO as they pertain to consultation, oral cancer management in underserved areas, patient education and e-learning applications.</p><p><strong>Conclusion and relevance: </strong>The utilisation of TOO is hindered by many challenges and this review addresses the potential limitations that prevent the integration of TOO in routine oral cancer care. A working model that circumvents the potential shortcomings of TOO is also proposed.</p>","PeriodicalId":73631,"journal":{"name":"Journal of cancer & allied specialties","volume":"6 1","pages":"e335"},"PeriodicalIF":0.0,"publicationDate":"2020-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.37029/jcas.v6i1.335","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9841106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Outcomes of Advanced Retinoblastoma Treated with Local Salvage Treatment; a Retrospective Case Series. 局部抢救治疗晚期视网膜母细胞瘤的疗效;回顾性案例系列。
Pub Date : 2020-01-06 eCollection Date: 2020-01-01 DOI: 10.37029/jcas.v6i1.283
Palwasha Rehman, Saadiya Javed Khan

Introduction: Retinoblastoma (RB) is the most common intraocular malignancy arising from the developing retina and occurs in approximately one of every 15,000-20,000 births. With the introduction of the intra-arterial chemotherapy (IAC), the 5-year overall survival of children with RB is 99%, though in low- and middle-income countries, it rarely exceeds 35% due to limited resources and lack of expertise. The aim of this study was to determine the outcome of local salvage in advanced RB.

Materials and methods: A retrospective analysis was conducted on children diagnosed with advanced RB that had local salvage therapy along with systemic chemotherapy from January 2015 to January 2018 at Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan.

Results: Fifteen patients were included in the study, among these 10 were male. The median age of presentation was 20 months (range 2-40 months). Among participants, 11 patients had bilateral RB. Fourteen patients received local control along with systemic chemotherapy. Relapse disease was seen in 12 patients and 2-year disease-free survival (DFS) was 20%.

Conclusion: The results of the present study suggest that centres lacking the resources for IAC should treat advance cases of RB with an upfront or early enucleation.

引言:视网膜母细胞瘤(RB)是由发育中的视网膜引起的最常见的眼内恶性肿瘤,大约每15000-20000名新生儿中就有一人发生。随着动脉内化疗(IAC)的引入,RB儿童的5年总生存率为99%,尽管在中低收入国家,由于资源有限和缺乏专业知识,这一比例很少超过35%。本研究的目的是确定晚期RB局部抢救的结果。材料和方法:对2015年1月至2018年1月在巴基斯坦拉合尔Shaukat Khanum纪念癌症医院和研究中心接受局部抢救治疗和全身化疗的诊断为晚期RB的儿童进行回顾性分析。结果:15名患者被纳入研究,其中10人为男性。表现的中位年龄为20个月(2-40个月)。在参与者中,11名患者患有双侧RB。14名患者接受了局部控制和全身化疗。12例患者出现复发,2年无病生存率(DFS)为20%。结论:本研究的结果表明,缺乏IAC资源的中心应该通过前期或早期摘除来治疗RB的晚期病例。
{"title":"Outcomes of Advanced Retinoblastoma Treated with Local Salvage Treatment; a Retrospective Case Series.","authors":"Palwasha Rehman,&nbsp;Saadiya Javed Khan","doi":"10.37029/jcas.v6i1.283","DOIUrl":"10.37029/jcas.v6i1.283","url":null,"abstract":"<p><strong>Introduction: </strong>Retinoblastoma (RB) is the most common intraocular malignancy arising from the developing retina and occurs in approximately one of every 15,000-20,000 births. With the introduction of the intra-arterial chemotherapy (IAC), the 5-year overall survival of children with RB is 99%, though in low- and middle-income countries, it rarely exceeds 35% due to limited resources and lack of expertise. The aim of this study was to determine the outcome of local salvage in advanced RB.</p><p><strong>Materials and methods: </strong>A retrospective analysis was conducted on children diagnosed with advanced RB that had local salvage therapy along with systemic chemotherapy from January 2015 to January 2018 at Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan.</p><p><strong>Results: </strong>Fifteen patients were included in the study, among these 10 were male. The median age of presentation was 20 months (range 2-40 months). Among participants, 11 patients had bilateral RB. Fourteen patients received local control along with systemic chemotherapy. Relapse disease was seen in 12 patients and 2-year disease-free survival (DFS) was 20%.</p><p><strong>Conclusion: </strong>The results of the present study suggest that centres lacking the resources for IAC should treat advance cases of RB with an upfront or early enucleation.</p>","PeriodicalId":73631,"journal":{"name":"Journal of cancer & allied specialties","volume":"6 1","pages":"e283"},"PeriodicalIF":0.0,"publicationDate":"2020-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3e/8c/JCAS-6-283.PMC10166347.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9841103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Notice of Retraction. 撤回通知。
Pub Date : 2020-01-06 eCollection Date: 2020-01-01 DOI: 10.37029/jcas.v6i1.329
Khawaja Shehryar Nasir

[This retracts the article DOI: 10.37029/jcas.v4i3.327.].

[这收回了文章DOI:10.37029/jcas.v4i3.327.]。
{"title":"Notice of Retraction.","authors":"Khawaja Shehryar Nasir","doi":"10.37029/jcas.v6i1.329","DOIUrl":"10.37029/jcas.v6i1.329","url":null,"abstract":"<p><p>[This retracts the article DOI: 10.37029/jcas.v4i3.327.].</p>","PeriodicalId":73631,"journal":{"name":"Journal of cancer & allied specialties","volume":"6 1","pages":"e329"},"PeriodicalIF":0.0,"publicationDate":"2020-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3f/86/JCAS-6-329.PMC10166319.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9541327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Skin Metastasis in Breast Cancer Patients; a Case Series. 乳腺癌患者皮肤转移的研究a案例系列。
Pub Date : 2020-01-01 DOI: 10.37029/jcas.v6i1.307
Sara Rehman, Muhammad Atif Naveed

Introduction: Breast cancer is the most common malignancy in women. It frequently metastasizes to bones, lungs and liver. Although rare, skin metastasis may also take place. It may also be the presenting feature of initial or recurrent breast cancer. The assessment of recurrent metastatic disease involving skin after mastectomy can be challenging because of the benign-appearing clinical presentation. The purpose of this case series was to explore the clinical and radiological presentation of skin metastasis in patients of breast cancer.

Materials and methods: This is a retrospective case series of breast cancer patients with skin lesions on chest and abdomen at the time of initial presentation, or post-treatment such as, after mastectomy or breast conservation therapy; who underwent various radiological investigations including mammography, ultrasound scan, computed tomography (CT) scan and magnetic resonance imaging from 1 May 2018 to 30 September 2019 at Shaukat Khanum Memorial Cancer Hospital and Research Centre, Pakistan.

Results: A total of eight cases were identified, out of which seven were females. The most common presentation consisted of the presence of metastatic nodules which were seen in 62.5% (five out of eight) of the patients. Other features consisted of erythematous or plaque-like skin thickening on clinical examination, increased density with indistinct margins seen on a mammogram and diffuse oedematous changes in the skin with small irregular mass or infiltration into subcutaneous tissues were visualised on ultrasound and CT studies.

Conclusion: Skin metastasis from breast cancer most commonly presents as nodules, although rarely they may present as plaques or diffuse skin thickening. Awareness of diverse manifestations of skin metastasis is of utmost importance in early diagnosis and management.

乳腺癌是女性中最常见的恶性肿瘤。它经常转移到骨骼、肺和肝脏。虽然罕见,但也可能发生皮肤转移。它也可能是原发性或复发性乳腺癌的表现特征。乳房切除术后复发性皮肤转移性疾病的评估可能具有挑战性,因为临床表现良好。本病例系列的目的是探讨乳腺癌患者皮肤转移的临床和放射学表现。材料和方法:这是一个回顾性的病例系列,乳腺癌患者在首次就诊时,或治疗后,如乳房切除术或保乳治疗后,胸部和腹部皮肤病变;于2018年5月1日至2019年9月30日在巴基斯坦Shaukat Khanum纪念癌症医院和研究中心接受了各种放射检查,包括乳房x光检查、超声扫描、计算机断层扫描(CT)和磁共振成像。结果:共发现8例,其中7例为女性。最常见的表现包括转移性结节的存在,在62.5%(8名患者中有5名)的患者中可见。其他特征包括临床检查时的红斑或斑块样皮肤增厚,乳房x光检查时密度增加,边缘不清,超声和CT检查时可见皮肤弥漫性水肿改变,伴有小不规则肿块或渗入皮下组织。结论:乳腺癌的皮肤转移最常表现为结节,尽管很少表现为斑块或弥漫性皮肤增厚。了解皮肤转移的各种表现对早期诊断和治疗至关重要。
{"title":"Skin Metastasis in Breast Cancer Patients; a Case Series.","authors":"Sara Rehman,&nbsp;Muhammad Atif Naveed","doi":"10.37029/jcas.v6i1.307","DOIUrl":"https://doi.org/10.37029/jcas.v6i1.307","url":null,"abstract":"<p><strong>Introduction: </strong>Breast cancer is the most common malignancy in women. It frequently metastasizes to bones, lungs and liver. Although rare, skin metastasis may also take place. It may also be the presenting feature of initial or recurrent breast cancer. The assessment of recurrent metastatic disease involving skin after mastectomy can be challenging because of the benign-appearing clinical presentation. The purpose of this case series was to explore the clinical and radiological presentation of skin metastasis in patients of breast cancer.</p><p><strong>Materials and methods: </strong>This is a retrospective case series of breast cancer patients with skin lesions on chest and abdomen at the time of initial presentation, or post-treatment such as, after mastectomy or breast conservation therapy; who underwent various radiological investigations including mammography, ultrasound scan, computed tomography (CT) scan and magnetic resonance imaging from 1 May 2018 to 30 September 2019 at Shaukat Khanum Memorial Cancer Hospital and Research Centre, Pakistan.</p><p><strong>Results: </strong>A total of eight cases were identified, out of which seven were females. The most common presentation consisted of the presence of metastatic nodules which were seen in 62.5% (five out of eight) of the patients. Other features consisted of erythematous or plaque-like skin thickening on clinical examination, increased density with indistinct margins seen on a mammogram and diffuse oedematous changes in the skin with small irregular mass or infiltration into subcutaneous tissues were visualised on ultrasound and CT studies.</p><p><strong>Conclusion: </strong>Skin metastasis from breast cancer most commonly presents as nodules, although rarely they may present as plaques or diffuse skin thickening. Awareness of diverse manifestations of skin metastasis is of utmost importance in early diagnosis and management.</p>","PeriodicalId":73631,"journal":{"name":"Journal of cancer & allied specialties","volume":"6 1","pages":"307"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.37029/jcas.v6i1.307","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9541329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
THE ROLE OF INTRAOPERATIVE FROZEN SECTION OF SENTINEL LYMPH NODES IN UPFRONT BREAST CONSERVATION CANCER SURGERY 术中前哨淋巴结冷冻切片在前期乳腺癌保乳手术中的作用
Pub Date : 2019-06-30 DOI: 10.37029/JCAS.V5I2.227
R. Khan, A. Malik, S. Mohtasham, A. Khan, M. Parvaiz, A. Loya
Objective: Sentinel lymph node biopsy is the standard of care in clinically negative axilla in breast cancer patients for which frozen section (FS) is routinely performed intraoperatively. The objective of this study was to justify the use of FS in terms of number of tests performed and their impact on decision-making and cost saving. Materials and Methods: We retrospectively reviewed our prospectively maintained data from January 2014 to January 2018 for intraoperative FS in upfront breast conservation surgery patients. Results: A total of 357 patients were studied. All were female. Median age was 50 years (24–84). Mean tumour size was 29.11 mm. Numbers of sentinel lymph nodes identified were 1 in 50 (14.2%) patients, 2 in 121 (33.89%) patients and ≥3 in 186 (52%) patients. Number of positive sentinel lymph nodes was 0 in 264 (73.9%) patients, 1 in 62 (17.4%) patients, 2 in 20 (5.6%) patients and ≥3 in 11 (3.08%) patients. Axillary lymph node dissection (ALND) was offered to 30 (8.4%) patients as per the American College of Surgeons Oncology Group Z0011. The results for ALND showed that only 8 (2.3%) out of 30 patients had positive nodes identified in the additional axillary nodes dissected. Sensitivity of FS was 97% and specificity was 98.86%. False-negative rate was 3.22%. Conclusion: Intraoperative FS can be safely omitted in early breast cancer patients undergoing upfront breast conservation cancer surgery due to high sensitivity and specificity leading to low false-negative rates. ALND can be performed as a second operation as warranted only in a minority of patients. Key words: American College of Surgeons Oncology Group Z0011 trial, axillary lymph node dissection, intraoperative frozen section, sentinel lymph node biopsy
目的:前哨淋巴结活检是临床阴性乳腺癌患者腋窝的标准护理,术中常规进行冷冻切片(FS)。本研究的目的是根据所进行的测试数量及其对决策和成本节约的影响来证明FS的使用是合理的。材料和方法:我们回顾性地回顾了2014年1月至2018年1月前期保乳手术患者术中FS的前瞻性数据。结果:共纳入357例患者。都是女性。中位年龄为50岁(24-84岁)。肿瘤平均大小为29.11 mm。前哨淋巴结的检出率为50例中有1例(14.2%),121例中有2例(33.89%),186例中≥3例(52%)。前哨淋巴结阳性264例(73.9%)为0个,62例(17.4%)为1个,20例(5.6%)为2个,≥3个(3.08%)为11例。根据美国外科医师学会肿瘤组Z0011,为30例(8.4%)患者提供腋窝淋巴结清扫(ALND)。ALND的结果显示,30例患者中只有8例(2.3%)在额外的腋窝淋巴结中发现阳性淋巴结。FS的敏感性为97%,特异性为98.86%。假阴性率为3.22%。结论:早期乳腺癌患者术前保乳手术术中可安全省略术中FS,其敏感性和特异性高,假阴性率低。ALND仅在少数患者中可作为第二次手术。关键词:美国外科学会肿瘤组Z0011试验,腋窝淋巴结清扫术,术中冷冻切片,前哨淋巴结活检
{"title":"THE ROLE OF INTRAOPERATIVE FROZEN SECTION OF SENTINEL LYMPH NODES IN UPFRONT BREAST CONSERVATION CANCER SURGERY","authors":"R. Khan, A. Malik, S. Mohtasham, A. Khan, M. Parvaiz, A. Loya","doi":"10.37029/JCAS.V5I2.227","DOIUrl":"https://doi.org/10.37029/JCAS.V5I2.227","url":null,"abstract":"Objective: Sentinel lymph node biopsy is the standard of care in clinically negative axilla in breast cancer patients for which frozen section (FS) is routinely performed intraoperatively. The objective of this study was to justify the use of FS in terms of number of tests performed and their impact on decision-making and cost saving. Materials and Methods: We retrospectively reviewed our prospectively maintained data from January 2014 to January 2018 for intraoperative FS in upfront breast conservation surgery patients. Results: A total of 357 patients were studied. All were female. Median age was 50 years (24–84). Mean tumour size was 29.11 mm. Numbers of sentinel lymph nodes identified were 1 in 50 (14.2%) patients, 2 in 121 (33.89%) patients and ≥3 in 186 (52%) patients. Number of positive sentinel lymph nodes was 0 in 264 (73.9%) patients, 1 in 62 (17.4%) patients, 2 in 20 (5.6%) patients and ≥3 in 11 (3.08%) patients. Axillary lymph node dissection (ALND) was offered to 30 (8.4%) patients as per the American College of Surgeons Oncology Group Z0011. The results for ALND showed that only 8 (2.3%) out of 30 patients had positive nodes identified in the additional axillary nodes dissected. Sensitivity of FS was 97% and specificity was 98.86%. False-negative rate was 3.22%. Conclusion: Intraoperative FS can be safely omitted in early breast cancer patients undergoing upfront breast conservation cancer surgery due to high sensitivity and specificity leading to low false-negative rates. ALND can be performed as a second operation as warranted only in a minority of patients. Key words: American College of Surgeons Oncology Group Z0011 trial, axillary lymph node dissection, intraoperative frozen section, sentinel lymph node biopsy","PeriodicalId":73631,"journal":{"name":"Journal of cancer & allied specialties","volume":"188 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78326658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SOLITARY FIBROUS TUMOR OF BREAST 乳腺孤立性纤维性肿瘤
Pub Date : 2019-06-30 DOI: 10.37029/JCAS.V5I2.231
S. Noor, N. Akhtar, Usman Hassan, M. Hameed
Solitary fibrous tumours (SFTs) are fibroblastic mesenchymal tumour primarily identified in the pleura but are now being reported in other anatomic sites as well. SFT is generally characterised as a radiologically confined neoplasm composed of a proliferated spindle cells arranged in patternless manner. Intervening tissue shows prominent haemangiopericytoma-like vessels. Stroma is usually fibrous. Tumour is positive for CD34. SFT has a specific translocation representing fusion NAB2 with STAT6 genes. This translocation can be highlighted with very good specificity and sensitivity using STAT6 immunohistochemical stain. Some cases of SFTs have also been described in the breast. Rarely, SFT can show aggressive behaviour. SFT enters the differential diagnoses of benign and malignant spindle cell tumours of breast and it is, therefore, important that its clinical, radiological and pathological features are known to clinicians and diagnosticians. Key words: CD34, myofibroblastoma, NAB2-STAT6, solitary fibrous tumour
孤立纤维性肿瘤(SFTs)是一种纤维母细胞间充质肿瘤,主要在胸膜中发现,但现在也报道了其他解剖部位。SFT通常表现为放射学局限的肿瘤,由无模式排列的增殖梭形细胞组成。中间组织可见明显的血管外皮细胞瘤样血管。基质通常是纤维状的。肿瘤CD34阳性。SFT具有特异的易位,代表NAB2与STAT6基因融合。使用STAT6免疫组织化学染色可以突出这种易位,具有非常好的特异性和敏感性。一些SFTs病例也被描述为发生在乳房。SFT很少会表现出攻击性行为。SFT进入乳腺良性和恶性梭形细胞肿瘤的鉴别诊断,因此,重要的是临床医生和诊断人员了解其临床、放射学和病理特征。关键词:CD34,肌成纤维细胞瘤,NAB2-STAT6,孤立性纤维性肿瘤
{"title":"SOLITARY FIBROUS TUMOR OF BREAST","authors":"S. Noor, N. Akhtar, Usman Hassan, M. Hameed","doi":"10.37029/JCAS.V5I2.231","DOIUrl":"https://doi.org/10.37029/JCAS.V5I2.231","url":null,"abstract":"Solitary fibrous tumours (SFTs) are fibroblastic mesenchymal tumour primarily identified in the pleura but are now being reported in other anatomic sites as well. SFT is generally characterised as a radiologically confined neoplasm composed of a proliferated spindle cells arranged in patternless manner. Intervening tissue shows prominent haemangiopericytoma-like vessels. Stroma is usually fibrous. Tumour is positive for CD34. SFT has a specific translocation representing fusion NAB2 with STAT6 genes. This translocation can be highlighted with very good specificity and sensitivity using STAT6 immunohistochemical stain. Some cases of SFTs have also been described in the breast. Rarely, SFT can show aggressive behaviour. SFT enters the differential diagnoses of benign and malignant spindle cell tumours of breast and it is, therefore, important that its clinical, radiological and pathological features are known to clinicians and diagnosticians. Key words: CD34, myofibroblastoma, NAB2-STAT6, solitary fibrous tumour","PeriodicalId":73631,"journal":{"name":"Journal of cancer & allied specialties","volume":"49 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83647956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RUPTURED INTRACRANIAL DERMOID CYST 破裂的颅内皮样囊肿
Pub Date : 2019-06-30 DOI: 10.37029/JCAS.V5I2.223
Taimoor Ali Tariq, Pir Abdul Ahad Aziz Qureshi, Muhammad Talha Yaseen Kaimkhani
-
-
{"title":"RUPTURED INTRACRANIAL DERMOID CYST","authors":"Taimoor Ali Tariq, Pir Abdul Ahad Aziz Qureshi, Muhammad Talha Yaseen Kaimkhani","doi":"10.37029/JCAS.V5I2.223","DOIUrl":"https://doi.org/10.37029/JCAS.V5I2.223","url":null,"abstract":"<jats:p>-</jats:p>","PeriodicalId":73631,"journal":{"name":"Journal of cancer & allied specialties","volume":"20 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80578915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
EWING’S SARCOMA: APPROACHING CENTURY SINCE THIS BONE CANCER MADE NEWS 尤文氏肉瘤:近一个世纪以来,这种骨癌成为新闻
Pub Date : 2019-06-30 DOI: 10.37029/JCAS.V5I2.263
Z. Fadoo, Mir Ibrahim Sajid
-
-
{"title":"EWING’S SARCOMA: APPROACHING CENTURY SINCE THIS BONE CANCER MADE NEWS","authors":"Z. Fadoo, Mir Ibrahim Sajid","doi":"10.37029/JCAS.V5I2.263","DOIUrl":"https://doi.org/10.37029/JCAS.V5I2.263","url":null,"abstract":"<jats:p>-</jats:p>","PeriodicalId":73631,"journal":{"name":"Journal of cancer & allied specialties","volume":"39 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90160599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CENTRAL NERVOUS SYSTEM RELAPSE OF MULTIPLE MYELOMA 中枢神经系统多发性骨髓瘤复发
Pub Date : 2019-03-31 DOI: 10.37029/JCAS.V5I1.199
M. Qubtia, M. Nasir, Memoona Mian, A. Hameed
Multiple myeloma (MM) is a plasma cell disorder primarily involving bone marrow. Extramedullary involvement is less common, with central nervous system (CNS) myelomatosis being a rare entity and such presentation carries extremely dismal prognosis. We present case of a 40 years old male with MM who was initially treated with 6 cycles of Cyclophosphamide, Thalidomide and Dexamethasone resulting in complete response. 2 years later he presented with CNS myelomatosis and scrotal involvement and was initially treated with Bortezomib and dexamethasone, cranial irradiation and intrathecal Methorexate, Cytarabine, Hydrocortisone (TRIO IT), along with radical orchiectomy and testicular radiation during the course of treatment. However, after initial response his disease showed clinical and radiological progression after 4 months of therapy. He was switched to high dose Methotrexate (HD-MTX) with TRIOITand later Lenalidamide and dexamethasone (Len/dex) was added to the above regimen. He continued to show good clinical response but his cytology remained persistently positive, therefore, HD-MTX was discontinued in the later course of treatment. Subsequently he was started on best supportive care only, when his neurological status deteriorated further. He survived almost 9 months after a diagnosis of CNS myelomatosis. Patients with multiple myeloma, presenting with neurological symptoms should always be investigated for the possibility of CNS MM. CNS relapse is a fatal disease with poor prognosis. Recommended treatment must include a systemic anti-MM regimen that crosses the BBB (ideally Immunomodulatory drugs (IMiDs) IMiDs-dexamethasone based therapy), CNS irradiation and intrathecal chemotherapy.Key words: Multiple myeloma, central nervous system myelomatosis, therapy
多发性骨髓瘤(MM)是一种主要累及骨髓的浆细胞疾病。髓外受累不常见,中枢神经系统(CNS)骨髓瘤病是一种罕见的实体,这种表现预后非常差。我们报告了一例40岁男性MM患者,他最初接受了6个周期的环磷酰胺、沙利度胺和地塞米松治疗,完全缓解。2年后,他出现中枢神经系统骨髓瘤病和阴囊受累,最初接受硼替佐米和地塞米松、颅照射和鞘内甲氨喋呤、阿糖胞苷、氢化可的松(TRIO IT)治疗,同时在治疗过程中进行根治性睾丸切除术和睾丸放射治疗。然而,在最初的反应后,他的疾病在治疗4个月后表现出临床和放射学进展。患者改用高剂量甲氨蝶呤(HD-MTX)联合trioitd治疗,后在上述方案中加入来那胺和地塞米松(Len/dex)。他继续表现出良好的临床反应,但他的细胞学仍然持续呈阳性,因此,在治疗的后期停止了HD-MTX。随后,当他的神经系统状况进一步恶化时,他开始接受最好的支持治疗。在被诊断为中枢神经系统骨髓瘤病后,他活了近9个月。出现神经系统症状的多发性骨髓瘤患者应经常检查中枢神经系统MM的可能性,中枢神经系统复发是一种预后不良的致命疾病。推荐的治疗方案必须包括通过血脑屏障的全身抗mm方案(理想情况下是免疫调节药物(IMiDs), IMiDs-地塞米松为基础的治疗),中枢神经系统照射和鞘内化疗。关键词:多发性骨髓瘤,中枢神经系统骨髓瘤,治疗
{"title":"CENTRAL NERVOUS SYSTEM RELAPSE OF MULTIPLE MYELOMA","authors":"M. Qubtia, M. Nasir, Memoona Mian, A. Hameed","doi":"10.37029/JCAS.V5I1.199","DOIUrl":"https://doi.org/10.37029/JCAS.V5I1.199","url":null,"abstract":"Multiple myeloma (MM) is a plasma cell disorder primarily involving bone marrow. Extramedullary involvement is less common, with central nervous system (CNS) myelomatosis being a rare entity and such presentation carries extremely dismal prognosis. We present case of a 40 years old male with MM who was initially treated with 6 cycles of Cyclophosphamide, Thalidomide and Dexamethasone resulting in complete response. 2 years later he presented with CNS myelomatosis and scrotal involvement and was initially treated with Bortezomib and dexamethasone, cranial irradiation and intrathecal Methorexate, Cytarabine, Hydrocortisone (TRIO IT), along with radical orchiectomy and testicular radiation during the course of treatment. However, after initial response his disease showed clinical and radiological progression after 4 months of therapy. He was switched to high dose Methotrexate (HD-MTX) with TRIOITand later Lenalidamide and dexamethasone (Len/dex) was added to the above regimen. He continued to show good clinical response but his cytology remained persistently positive, therefore, HD-MTX was discontinued in the later course of treatment. Subsequently he was started on best supportive care only, when his neurological status deteriorated further. He survived almost 9 months after a diagnosis of CNS myelomatosis. Patients with multiple myeloma, presenting with neurological symptoms should always be investigated for the possibility of CNS MM. CNS relapse is a fatal disease with poor prognosis. Recommended treatment must include a systemic anti-MM regimen that crosses the BBB (ideally Immunomodulatory drugs (IMiDs) IMiDs-dexamethasone based therapy), CNS irradiation and intrathecal chemotherapy.Key words: Multiple myeloma, central nervous system myelomatosis, therapy","PeriodicalId":73631,"journal":{"name":"Journal of cancer & allied specialties","volume":"52 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91298430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of cancer & allied specialties
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1